Published in Ann Microbiol (Paris) on October 21, 1982
Rapid in vitro metabolic screen for antileprosy compounds. Antimicrob Agents Chemother (1987) 1.28
Mycobacterium leprae surface components intervene in the early phagosome-lysosome fusion inhibition event. Infect Immun (1987) 1.17
Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell (1991) 7.17
Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1972) 4.64
Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species. J Clin Microbiol (1997) 4.00
Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives. Emerg Infect Dis (2001) 3.89
Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclature. Int J Tuberc Lung Dis (2001) 3.82
Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol (1970) 3.65
Mycobacterium tuberculosis phylogeny reconstruction based on combined numerical analysis with IS1081, IS6110, VNTR, and DR-based spoligotyping suggests the existence of two new phylogeographical clades. J Mol Evol (2001) 3.21
Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? Antimicrob Agents Chemother (1981) 3.16
Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome. J Clin Microbiol (1987) 3.01
Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect Immun (1986) 2.71
Functional analysis of pAL5000, a plasmid from Mycobacterium fortuitum: construction of a "mini" mycobacterium-Escherichia coli shuttle vector. J Bacteriol (1990) 2.63
A data-mining approach to spacer oligonucleotide typing of Mycobacterium tuberculosis. Bioinformatics (2002) 2.62
Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1991) 2.31
Drug susceptibility testing in tuberculosis: a comparison of the proportion methods using Lowenstein-Jensen, Middlebrook 7H10 and 7H11 agar media and a radiometric method. Res Microbiol (1990) 2.25
Genetic diversity of Mycobacterium africanum clinical isolates based on IS6110-restriction fragment length polymorphism analysis, spoligotyping, and variable number of tandem DNA repeats. J Clin Microbiol (2001) 2.22
Use of cetylpyridinium chloride and sodium chloride for the decontamination of sputum specimens that are transported to the laboratory for the isolation of Mycobacterium tuberculosis. J Clin Microbiol (1975) 2.21
Tuberculosis in the Caribbean: using spacer oligonucleotide typing to understand strain origin and transmission. Emerg Infect Dis (1999) 2.14
Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun (1996) 1.98
Integration of tuberculosis screening at an HIV voluntary counselling and testing centre in Haiti. AIDS (2001) 1.90
IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80
Burden of unidentifiable mycobacteria in a reference laboratory. J Clin Microbiol (2001) 1.79
Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob Agents Chemother (1990) 1.72
Spoligotype signatures in the Mycobacterium tuberculosis complex. J Clin Microbiol (2006) 1.71
[Behavior of mesosomes at the time of attack of Bacillus subtilis by lysozyme in a hyper- or hypotonic medium]. C R Acad Sci Hebd Seances Acad Sci D (1967) 1.68
Basis for lack of drug susceptibility of atypical mycobacteria. Rev Infect Dis (1982) 1.63
Mycolic acid analysis for clinical identification of Mycobacterium avium and related mycobacteria. J Clin Microbiol (1986) 1.61
Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infect Immun (1993) 1.60
Identification of Mycobacterium fortuitum and Mycobacterium chelonei. J Clin Microbiol (1983) 1.57
Detection of a previously unamplified spacer within the DR locus of Mycobacterium tuberculosis: epidemiological implications. J Clin Microbiol (2000) 1.56
Effect of temperature on the rate of the transparent to opaque colony type transition in Mycobacterium avium. Antimicrob Agents Chemother (1976) 1.56
An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci U S A (1997) 1.55
Spoligotyping followed by double-repetitive-element PCR as rapid alternative to IS6110 fingerprinting for epidemiological studies of tuberculosis. J Clin Microbiol (1998) 1.47
The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J Biol Chem (2001) 1.46
Mechanisms of pathogenicity in mycobacteria. Biochimie (1988) 1.45
Some observations on the genetics of isoniazid resistance in the tubercle bacilli. Am Rev Respir Dis (1971) 1.45
PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia. Eur J Clin Microbiol Infect Dis (2003) 1.45
Evaluation of the chloride and bromide salts of cetylpyridium for the transportation of sputum in tuberculosis bacteriology. Tubercle (1979) 1.44
Structure of the cell envelope of Mycobacterium avium. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 1.41
Molecular fingerprinting of Mycobacterium tuberculosis on a Caribbean island with IS6110 and DRr probes. J Clin Microbiol (1997) 1.40
[Electron microscope study of cell wall growth in B. subtilis and B. megaterium]. Ann Inst Pasteur (Paris) (1971) 1.39
Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000. Ann Inst Pasteur Microbiol (1986) 1.38
ClpE, a novel member of the HSP100 family, is involved in cell division and virulence of Listeria monocytogenes. Mol Microbiol (1999) 1.38
Comparative evaluation of PCR and commercial DNA probes for detection and identification to species level of Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol (1996) 1.38
Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. Microb Pathog (2000) 1.37
Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J Clin Microbiol (2004) 1.36
Response of Mycobacteria to ultraviolet light radiation. Am Rev Respir Dis (1973) 1.36
Molecular characterization of Mycobacterium avium complex isolates giving discordant results in AccuProbe tests by PCR-restriction enzyme analysis, 16S rRNA gene sequencing, and DT1-DT6 PCR. J Clin Microbiol (1997) 1.35
Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene (1991) 1.32
beta-Glucosidase activity in mycobacteria. J Clin Microbiol (1977) 1.32
Genetic diversity of Mycobacterium tuberculosis in Sicily based on spoligotyping and variable number of tandem DNA repeats and comparison with a spoligotyping database for population-based analysis. J Clin Microbiol (2001) 1.30
Recent studies on mycobacterial differentiation by means of pyrolysis-gas-liquid chromatography. Am Rev Respir Dis (1971) 1.30
Evaluation of Amplicor MTB test as adjunct to smears and culture for direct detection of Mycobacterium tuberculosis in the French Caribbean. J Clin Microbiol (1996) 1.29
Molecular typing of Mycobacterium tuberculosis based on variable number of tandem DNA repeats used alone and in association with spoligotyping. J Clin Microbiol (2000) 1.28
Expression of Escherichia coli beta-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses. Mol Microbiol (1992) 1.27
Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann Immunol (Paris) (1983) 1.23
Acridine orange as a fluorescent counterstain with the auramine acid-fast stain. Tubercle (1971) 1.22
Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine. Am Rev Respir Dis (1969) 1.21
BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route. Tuber Lung Dis (1993) 1.20
Use of spoligotyping to study the evolution of the direct repeat locus by IS6110 transposition in Mycobacterium tuberculosis. J Clin Microbiol (2001) 1.19
Methods used in the molecular epidemiology of tuberculosis. Clin Microbiol Infect (2002) 1.18
Mycobacterium leprae surface components intervene in the early phagosome-lysosome fusion inhibition event. Infect Immun (1987) 1.17
[Evaluation of urease and beta-glucosidase activity for the practical identification of mycobacteria (author's transl)]. Ann Microbiol (Paris) (1979) 1.17
Serological specificity of Mycobacterium tuberculosis glycolipids. Acta Leprol (1989) 1.16
The electron-transparent zone in phagocytized Mycobacterium avium and other mycobacteria: formation, persistence and role in bacterial survival. Ann Inst Pasteur Microbiol (1988) 1.16
Electron microscopic study of Bacillus subtilis protoplast fusion. J Bacteriol (1979) 1.16
[Fractionation and purification of cytpplasmic membrane and mesosome systeme of Bacillus subtilis. Study of some of their redox properties associated with the respiratory chain]. Biochim Biophys Acta (1970) 1.16
Differential identification of Mycobacterium fortuitum and Mycobacterium chelonei. J Clin Microbiol (1981) 1.15
Combined numerical analysis based on the molecular description of Mycobacterium tuberculosis by four repetitive sequence-based DNA typing systems. Res Microbiol (1998) 1.15
Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect Immun (1991) 1.15
Rapid differentiation of "Mycobacterium canettii" from other Mycobacterium tuberculosis complex organisms by PCR-restriction analysis of the hsp65 gene. J Clin Microbiol (2001) 1.14
Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J Leukoc Biol (1994) 1.13
Description of a novel Mycobacterium simiae allelic variant isolated from Caribbean AIDS patients by PCR-restriction enzyme analysis and sequencing of hsp65 gene. Mol Cell Probes (2000) 1.12
Preliminary observations on the occurrence of a streptomycin R-factor in Mycobacterium smegmatis ATCC 607. Tubercle (1972) 1.12
Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice. Microbiology (1995) 1.11
Impact of immigration on tuberculosis epidemiology in a low-incidence country. Clin Microbiol Infect (2010) 1.10
[Cytologic study of sporulation in Clostridium histolyticum. Sporogenous strain and sporulation mutants]. Ann Inst Pasteur (Paris) (1967) 1.09
Epidemiological and genetic markers, virulence factors and intracellular growth of Mycobacterium avium in AIDS. Res Microbiol (1992) 1.09
Identification of a PEST-like motif in listeriolysin O required for phagosomal escape and for virulence in Listeria monocytogenes. Mol Microbiol (2001) 1.08
Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect Immun (1995) 1.07
Evaluation of a novel 2,3-diacyl-trehalose-2'-sulphate (SL-IV) antigen for case finding and diagnosis of leprosy and tuberculosis. Res Microbiol (1991) 1.07
Antibacterial action of amphipathic derivatives of isoniazid against the Mycobacterium avium complex. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 1.06
Correlation between degradation and ultrastructure of peptidoglycan during autolysis of Escherichia coli. J Bacteriol (1985) 1.05
Glycolipids of recent clinical isolates of Mycobacterium tuberculosis: chemical characterization and immunoreactivity. J Gen Microbiol (1989) 1.04
Susceptibility of mycobacteria to rifampin. Antimicrob Agents Chemother (1972) 1.04
Mycobacteriophage D29 contains an integration system similar to that of the temperate mycobacteriophage L5. Microbiology (1997) 1.04
Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen. Vaccine (1993) 1.03
Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium. Antimicrob Agents Chemother (1993) 1.03
Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium avium. Infect Immun (1993) 1.03
Conjugative transfer of a shuttle plasmid from Escherichia coli to Mycobacterium smegmatis [corrected]. FEMS Microbiol Lett (1990) 1.03
Association of Mycobacterium tuberculosis complex isolates of BOVIS and Central Asian (CAS) genotypic lineages with extrapulmonary disease. Clin Microbiol Infect (2009) 1.02
Follow up of Mycobacterium tuberculosis transmission in the French West Indies by IS6110-DNA fingerprinting and DR-based spoligotyping. FEMS Immunol Med Microbiol (1998) 1.02
Classification and identification of Mycobacterium africanum by pyrolysis mass spectrometry. J Gen Microbiol (1983) 1.02
Carcinoma of esophagus with unusual metastasis to gingiva and phalanx. Indian J Cancer (2004) 1.01
Preparation of a stable mycobacterial tween hydrolysis test substrate. Appl Microbiol (1973) 1.01
Molecular characterization of a surface-exposed superoxide dismutase of Mycobacterium avium. Microb Pathog (1996) 1.00
Recombinant BCG strains expressing the SIVmac251nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine (1995) 1.00